Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL), Climb Bio (CLYM) and Henry Schein (HSIC)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on QuidelOrtho (QDEL), Climb Bio (CLYM) and Henry Schein (HSIC).
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
QuidelOrtho (QDEL)
William Blair analyst Andrew Brackmann maintained a Hold rating on QuidelOrtho today and set a price target of $11.66. The company’s shares closed last Tuesday at $11.66.
According to TipRanks.com, Brackmann is a 4-star analyst with an average return of
QuidelOrtho has an analyst consensus of Hold, with a price target consensus of $18.42, which is a 48.1% upside from current levels. In a report issued on April 21, TipRanks – xAI also reiterated a Hold rating on the stock with a $12.00 price target.
See the top stocks recommended by analysts >>
Climb Bio (CLYM)
In a report released yesterday, Julian Harrison from BTIG maintained a Buy rating on Climb Bio, with a price target of $19.00. The company’s shares closed last Tuesday at $11.45, close to its 52-week high of $11.55.
According to TipRanks.com, Harrison is a top 100 analyst with an average return of
Climb Bio has an analyst consensus of Strong Buy, with a price target consensus of $18.25, an 83.8% upside from current levels. In a report issued on April 20, TipRanks – Google also upgraded the stock to Buy with a $10.00 price target.
Henry Schein (HSIC)
BTIG analyst David Larsen maintained a Hold rating on Henry Schein yesterday. The company’s shares closed last Tuesday at $74.37.
According to TipRanks.com, Larsen is ranked 0 out of 5 stars with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Henry Schein with a $89.00 average price target, representing a 24.5% upside. In a report released yesterday, TipRanks – Google also downgraded the stock to Hold with a $75.00 price target.
Read More on QDEL:
